Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
03/03/2011 | US20110052537 Nitro-based explosive remediation |
03/03/2011 | US20110052535 Compositions for treating an inflammatory autoimmune condition |
03/03/2011 | US20110052533 Compositions and Methods for Cartilage Repair |
03/03/2011 | US20110052530 Adoptive cell therapy with young t cells |
03/03/2011 | US20110052529 Methods and compositions for expanding t regulatory cells |
03/03/2011 | US20110052526 Method and composition for neochondrogenesis |
03/03/2011 | US20110052500 TAJ in Neuronal Function |
03/03/2011 | DE102009039191A1 Preparing substance, useful e.g. for treating physical illness, preferably prostate illness, comprises stirring peeled, sterilized and ground wheat grains in boiling water, incubating with microorganisms, and fermenting obtained suspension |
03/03/2011 | DE102009038634A1 Agent, useful e.g. for adjuvant therapy of AIDS diseases, HIV-1 or HIV-2 disease, comprises silicate mineral and optionally further materials |
03/03/2011 | DE102009037089A1 Zusammensetzung mit Stämmen von Lactobazillus fermentum Composition with Lactobacillus fermentum strains of |
03/03/2011 | CA2772551A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
03/03/2011 | CA2772441A1 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins |
03/03/2011 | CA2772163A1 Bifidobacterium longum and functional gi disorders |
03/02/2011 | EP2289552A1 An immunosuppressive agent plus anti-TCR antibodies for the induction of chimerism in transplantation |
03/02/2011 | EP2289527A1 Bifidobacterium longum and functional GI disorders |
03/02/2011 | EP2289526A1 Muscle derived cells (MDCs) for promoting and enhancing nerve repair and regeneration. |
03/02/2011 | EP2289525A1 Use of IL-21 for expanding lymphoid cells and for anticancer adoptive immunotherapy |
03/02/2011 | EP2288700A1 Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof |
03/02/2011 | EP2288396A2 Stimulation of cartilage formation using reduced pressure treatment and chondrocytes |
03/02/2011 | EP2288360A1 Isolated lactobacillus plantarum strain inducia dsm 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it |
03/02/2011 | EP2288359A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
03/02/2011 | EP2288358A1 Method of isolating biomacromolecules using polyalkylene glycol and transition metals |
03/02/2011 | EP1885382B1 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
03/02/2011 | EP1640716B1 Blood cell separation membrane and blood retention tool including the same |
03/02/2011 | EP1436403B1 Use of the adenoviral e2 late promoter |
03/02/2011 | EP1368456B1 Anti-bacterial vaccine compositions |
03/02/2011 | EP1363663B1 Nucleic acid mucosal immunization |
03/02/2011 | EP1185662B1 Dna vaccines for dogs |
03/02/2011 | CN1646157B Multiple and multivalent DNA vaccines in ovo |
03/02/2011 | CN1568195B Peptide YY and peptide YY agonists for treatment of metabolic disorders |
03/02/2011 | CN101983065A Agents for promoting secretion and/or suppressing decrease of adiponectin |
03/02/2011 | CN101982196A Traditional Chinese medicine composition for treating lung cancer, preparation method and application thereof |
03/02/2011 | CN101982195A Medicine for treating rheumatoid arthritis pain and preparation method thereof |
03/02/2011 | CN101982182A Medicine for treating burn and scald and preparation method thereof |
03/02/2011 | CN101982181A Method for building 7-day-old mouse model infected with enterovirus 71 |
03/02/2011 | CN101982180A Novel probiotic viable bacteria vaginal suppository body |
03/02/2011 | CN101982179A Xiao er Anfen Huang Namin granule and preparation method thereof |
03/02/2011 | CN101982178A Method for building mouse model for human colon carcinoma xenograft |
03/02/2011 | CN101628088B Traditional Chinese medicine composition for treating dermatosis |
03/02/2011 | CN101417079B Traditional Chinese medicine combination for treating endometriosis |
03/02/2011 | CN101413012B Method for inducing differentiation of mesenchyma stem cell into islet beta-like cells, and use thereof |
03/02/2011 | CN101406532B Medicament for mainly curing rheumatism |
03/02/2011 | CN101385827B Sea cucumber health paste and production method thereof |
03/02/2011 | CN101301023B Pilose antler deer penis collagen polypeptide, and preparation and produced oral preparation thereof |
03/01/2011 | US7897740 Secreted protein called 36P6D5 characteristic of tumors |
03/01/2011 | US7897384 Chondrocyte therapeutic delivery system |
03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
03/01/2011 | CA2342203C Method for removal of hiv and other viruses from blood |
03/01/2011 | CA2217820C Milk and milk products for preventing or treating heart disease |
02/24/2011 | WO2011022369A2 Method for processing tissues |
02/24/2011 | WO2011022071A2 Cardiac compositions |
02/24/2011 | WO2011022070A2 Perivascular stem cell composition for bone |
02/24/2011 | WO2011022045A2 Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use |
02/24/2011 | WO2011021933A1 Diabetes treatment |
02/24/2011 | WO2011021916A2 Use of egf-like domain of heregulin beta 1 peptide |
02/24/2011 | WO2011021503A1 Pharmaceutical composition containing transiently surviving ctl |
02/24/2011 | WO2011021209A1 Histone deacetylase inhibitors |
02/24/2011 | WO2011020957A1 Antibacterial food composition |
02/24/2011 | WO2011020780A1 A nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children. |
02/24/2011 | WO2011020748A1 A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children |
02/24/2011 | WO2011020311A1 Use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer |
02/24/2011 | WO2010144059A3 Novel uses |
02/24/2011 | WO2010132764A3 Live-attenuated compositions for bacterial infections |
02/24/2011 | WO2010111443A3 Omentum as a source of stromal/stem cells and medical treatments using omentum stromal/stem cells |
02/24/2011 | WO2010104575A3 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
02/24/2011 | WO2010043772A3 Method of protecting cells |
02/24/2011 | WO2010007502A8 Platelet fraction deriving from placental blood |
02/24/2011 | US20110047631 Heat shock protein deficiencies as model systems for brain pathology and cancer |
02/24/2011 | US20110045590 Calcium-influx inhibitory factor and method of isolation thereof |
02/24/2011 | US20110045589 Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells |
02/24/2011 | US20110045583 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
02/24/2011 | US20110045569 Enzymatic conversion of blood group a, b, and ab red blood cells using alpha-n- acetylgalactosaminidases and alpha-galactosidases with unique substrate specificities and kinetic properties |
02/24/2011 | US20110045099 Nutraceutical composition and methods of use |
02/24/2011 | US20110045098 Excitatory glycine receptors and methods |
02/24/2011 | US20110045091 Anti-angiogenesis, anticancer proliferation properties of lymphocytic-derived microparticles |
02/24/2011 | US20110045084 Light-curable bone growth material for treating dental bone defects |
02/24/2011 | US20110045079 Dry powders of cellular material |
02/24/2011 | US20110045077 Encapsulated pancreatic islet cell products and methods of use thereof |
02/24/2011 | US20110045071 Generation of a novel type of anti-inflammatory macrophages for clinical use |
02/24/2011 | US20110045067 Soft gel capsules |
02/24/2011 | US20110045058 Transfection reagent |
02/24/2011 | US20110045054 Materials and methods for treating and managing plaque disease |
02/24/2011 | US20110045053 Isolated population of luminal stem cells that give rise to prostate cancer and methods of using same |
02/24/2011 | US20110045051 Extracellular matrix comprising platelet factors |
02/24/2011 | US20110045045 Production of and uses for decellularized lung tissue |
02/24/2011 | US20110045044 Compositions for repair of defects in tissues, and methods of making the same |
02/24/2011 | US20110045023 Recombinant RSV Virus Expression Systems And Vaccines |
02/24/2011 | US20110044997 Methods |
02/24/2011 | US20110044962 Notch induced natural killer cell generation and therapeutic uses |
02/24/2011 | US20110044961 Generation of Induced Pluripotent Stem Cells from Cord Blood |
02/24/2011 | US20110044960 Medicament, dental material, and method of screening |
02/24/2011 | US20110044959 Novel composition of stem cells for transplantation tolerance |
02/24/2011 | US20110044958 Activated mesenchymal stem cells for the prevention and repair of inflammatory states |
02/24/2011 | US20110044957 Methods and systems for extended in vitro culture of neuronal cells |
02/24/2011 | US20110044956 Nell-1 enhanced bone mineralization |
02/24/2011 | US20110044955 Altering memory by affecting staufen |
02/24/2011 | US20110044954 Methods of producing germ-like cells and related therapies |
02/24/2011 | US20110044953 Methods and Compositions for Localized Secretion of Anti-CTLA-4 Antibodies |
02/24/2011 | US20110044952 Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors |
02/24/2011 | US20110044951 Compositions for preparing a coffee beverage comprising hydrolysed chlorogenic acid |